A. Wessling

432 total citations
17 papers, 369 citations indexed

About

A. Wessling is a scholar working on Economics and Econometrics, Family Practice and Pulmonary and Respiratory Medicine. According to data from OpenAlex, A. Wessling has authored 17 papers receiving a total of 369 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Economics and Econometrics, 3 papers in Family Practice and 3 papers in Pulmonary and Respiratory Medicine. Recurrent topics in A. Wessling's work include Respiratory and Cough-Related Research (3 papers), Medication Adherence and Compliance (3 papers) and Health Systems, Economic Evaluations, Quality of Life (2 papers). A. Wessling is often cited by papers focused on Respiratory and Cough-Related Research (3 papers), Medication Adherence and Compliance (3 papers) and Health Systems, Economic Evaluations, Quality of Life (2 papers). A. Wessling collaborates with scholars based in Sweden, New Zealand and Norway. A. Wessling's co-authors include Arne Melander, Juan Merlo, Ulf Bergman, Göran Boëthius, B Westerholm, Ylva Tomson, Göran Tomson, DG McDevitt, Ingebjørg Baksaas and P. K. M. Lunde and has published in prestigious journals such as Acta Paediatrica, European Journal of Clinical Pharmacology and Journal of Clinical Pharmacy and Therapeutics.

In The Last Decade

A. Wessling

17 papers receiving 343 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
A. Wessling Sweden 10 81 75 57 54 50 17 369
S. Troy McMullin United States 7 77 1.0× 235 3.1× 75 1.3× 73 1.4× 77 1.5× 12 424
Jerry Avorn United States 7 79 1.0× 84 1.1× 120 2.1× 27 0.5× 140 2.8× 9 455
Josep Maria Arnau Spain 10 69 0.9× 170 2.3× 63 1.1× 112 2.1× 48 1.0× 17 490
Steve Hutchison United States 6 72 0.9× 153 2.0× 38 0.7× 52 1.0× 21 0.4× 6 438
Karen E. Bertch United States 7 62 0.8× 155 2.1× 51 0.9× 90 1.7× 19 0.4× 13 313
John Papastergiou Canada 12 45 0.6× 95 1.3× 42 0.7× 42 0.8× 36 0.7× 29 437
Richard S Slavik Canada 14 37 0.5× 105 1.4× 56 1.0× 36 0.7× 33 0.7× 31 531
Larry A. Dent United States 9 33 0.4× 86 1.1× 75 1.3× 39 0.7× 14 0.3× 9 345
Karolina Antonov Sweden 13 144 1.8× 256 3.4× 100 1.8× 90 1.7× 35 0.7× 16 569
Jutta Krappweis Germany 13 54 0.7× 103 1.4× 108 1.9× 172 3.2× 62 1.2× 26 512

Countries citing papers authored by A. Wessling

Since Specialization
Citations

This map shows the geographic impact of A. Wessling's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A. Wessling with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A. Wessling more than expected).

Fields of papers citing papers by A. Wessling

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A. Wessling. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A. Wessling. The network helps show where A. Wessling may publish in the future.

Co-authorship network of co-authors of A. Wessling

This figure shows the co-authorship network connecting the top 25 collaborators of A. Wessling. A scholar is included among the top collaborators of A. Wessling based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A. Wessling. A. Wessling is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Wessling, A., Wolfgang Wölwer, Stephan Heres, et al.. (2005). Telefon-Hotline als niederschwelliges Angebot für Fragen zur Schizophrenie. Der Nervenarzt. 77(9). 1105–1110. 2 indexed citations
2.
Ekedahl, Anders, A. Wessling, & Arne Melander. (2002). Primary non-compliance with automated prescription transmittals from health care centres in Sweden. Lund University Publications (Lund University). 19(4). 40–137. 5 indexed citations
3.
Carlsten, A., et al.. (1999). Utilisation of codeine and propoxyphene: geographic and demographic variations in prescribing, prescriber and recipient categories. European Journal of Clinical Pharmacology. 55(8). 605–611. 7 indexed citations
4.
Merlo, Juan, A. Wessling, & Arne Melander. (1996). Comparison of dose standard units for drug utilisation studies. European Journal of Clinical Pharmacology. 50(1-2). 27–30. 106 indexed citations
5.
Wessling, A., et al.. (1995). Pharmaceutical care for patients with skin diseases: a campaign year at Swedish pharmacies. Journal of Clinical Pharmacy and Therapeutics. 20(6). 327–334. 19 indexed citations
6.
Wessling, A. & Göran Boëthius. (1995). [Steady increase in antibiotic prescriptions to children. What are we treating?].. PubMed. 92(18). 1907–9. 1 indexed citations
7.
Merlo, Juan, et al.. (1994). Age standardisation of drug utilisation: comparisons of different methods using cardiovascular drug data from Sweden and Spain. European Journal of Clinical Pharmacology. 46(5). 393–8. 17 indexed citations
8.
Tomson, Ylva, A. Wessling, & Göran Tomson. (1994). General practitioners for rational use of drugs. European Journal of Clinical Pharmacology. 47(3). 213–219. 21 indexed citations
9.
Wessling, A., et al.. (1991). Monitoring of Drug Prescriptions for Children in the County of Jämtland and in Sweden as a Whole in 1977–1987. Acta Paediatrica. 80(10). 944–952. 16 indexed citations
10.
Wessling, A., Ulf Bergman, & B Westerholm. (1991). On the differences in psychotropic drug use between the three major urban areas in Sweden. European Journal of Clinical Pharmacology. 40(5). 495–500. 25 indexed citations
11.
Wessling, A., et al.. (1990). Measurement of drug use in a defined population. European Journal of Clinical Pharmacology. 39(3). 207–210. 44 indexed citations
12.
Wessling, A., Göran Boëthius, & Folke Sjöqvist. (1990). Prescription monitoring of drug dosages in the county of J�mtland and Sweden as a whole in 1976, 1982 and 1985. European Journal of Clinical Pharmacology. 38(4). 329–334. 8 indexed citations
13.
Wessling, A.. (1987). Over-the-counter sales of drugs in Sweden 1976–1983. European Journal of Clinical Pharmacology. 33(1). 1–6. 5 indexed citations
14.
Wessling, A.. (1987). Continuous recording of drug prescribing in Sweden 1974–1983. Methods and examples of utilization of data. European Journal of Clinical Pharmacology. 33(1). 7–13. 21 indexed citations
15.
Griffiths, Kathryn, DG McDevitt, M Andrew, et al.. (1986). Therapeutic traditions in Northern Ireland, Norway and Sweden: I. Diabetes. European Journal of Clinical Pharmacology. 30(5). 513–519. 32 indexed citations
16.
Griffiths, Kathryn, DG McDevitt, M Andrew, et al.. (1985). Validation of observed differences in the utilization of antihypertensive and antidiabetic drugs in Northern Ireland, Norway and Sweden. European Journal of Clinical Pharmacology. 29(1). 1–8. 31 indexed citations
17.
Bergman, Ulf, et al.. (1985). [The Gotland's study: high prescription rate of diabetic agents but also high morbidity].. PubMed. 82(12). 1051–4. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026